← FDA Drug Approvals (Drugs@FDA)

SER-AP-ES

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1960-02-11

Drug application

FDA Application #

NDA012193

Application type

New Drug Application

Brand name

SER-AP-ES

Generic name

Hydralazine Hydrochloride

Active ingredients

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1960-02-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown